Pfizer Unit Biohaven Settles False Claims Case for $60 Million

MT Newswires Live
02-04

Pfizer's (PFE) Biohaven agreed to a nearly $60 million nationwide settlement for submitting false claims to Medicaid and other government healthcare programs, California Attorney General Rob Bonta said Monday.

The settlement resolves allegations that Biohaven engaged in a kickback scheme from 2020 to 2022, offering cash and gifts to healthcare providers in exchange for Nurtec prescriptions, according to the Bonta.

Pfizer will make the payment of $59.7 million plus interest on behalf of Biohaven and it will be shared by the federal government and several states including California, whose share is $413,776, the state's Attorney General added.

Neither Pfizer nor Biohaven immediately responded to MT Newswires' requests for comment.

Price: 26.26, Change: -0.26, Percent Change: -0.98

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10